Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 4P30CA016059-35
Massey Cancer Center Support Grant
National Institutes of Health
Grant: 7R35GM143014-03
Nucleic Acid Modulators and Theranostics for ADAR
National Institutes of Health
Grant: 7R01CA266981-02
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
National Institutes of Health
Grant: 3P30CA046592-31S7
Cancer Center Support Grant 2018-2023
National Institutes of Health
Grant: 1R01CA286122-01A1
Multivalent Small Circular mRNA Vaccines for Melanoma Combination Immunotherapy
National Institutes of Health
Grant: 5R01AI168684-02
Small circular mRNA vaccines
Keywords